U.S. health officials are closely monitoring COVID-19 activity in the U.K., where cases and hospitalizations are simultaneously rising due to omicron subvariant BA.2, though many experts say it’s too soon to accurately predict if or when a similar uptick in virus activity may hit the U.S.
